SciELO - Scientific Electronic Library Online

 
vol.79 issue3Risk of Suffering from Cardiovascular Diseases because of the Clustering of the Modifiable Cardiovascular Risk Factors in the Population Older than 15 years of a Health Care Center in BarcelonaFactors Related to the Use of Inhaled and Intravenous Heroin, Granada, Spain author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Revista Española de Salud Pública

On-line version ISSN 2173-9110Print version ISSN 1135-5727

Abstract

LALLANA ALVAREZ, Mª Jesús  and  RABANAQUE HERNANDEZ, Mª José. Variability in the Use of New Drugs in a Primary Care District. Rev. Esp. Salud Publica [online]. 2005, vol.79, n.3, pp.379-389. ISSN 2173-9110.

Background: The use of new drugs has undergone a major increase in recent years. This study is aimed at ascertaining the degree to which pharmaceutical novelties are being used in one healthcare district in Zaragoza, describing which are those most used and the trend thereof over the course of time in addition to analyzing the characteristics of those centers associated with a greater use of these drugs. Methods: A descriptive study analyzing all of the dispensations of fifty new active ingredients marketed within the January 1, 2000 - December 31, 2003 period in one healthcare district. The percentage of use of novelties throughout the first year these drugs were marketed at each primary care center was calculated, the characteristics of those centers associated with a greater degree of innovation having been analyzed. Results: Seventy-six percent of the fifty new drugs marketed were barely innovative in comparison to the existing ones. The ten new drugs most prescribed began being used during the first four months immediately after coming out on the market. The percentage of use of new drugs as compared to all of the drugs prescribed at the healthcare centers studied fell within the 0.3% -1.18% range. In the analysis made by centers, the «per-patient expense» and the «consultations per physician» are positively correlated with a greater use of new drugs, whilst the percentage of retirees showed a reverse ratio. Conclusions: A high degree of variability exists in the percentage of use of pharmaceutical novelties among the primary care centers. The centers having the largest number of consultations per physician are those tending toward more readily incorporating these new drugs.

Keywords : Drug utilization; Primary health care.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License